-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R+G7HpUz3TKczUP/BbXcRA2409n8bVM6Criy4BU0arBDE56pfnGOIJfvan6dFbgk
 Hfj2BwrIcdih/OSrONpq2Q==

<SEC-DOCUMENT>0000930413-07-007411.txt : 20070912
<SEC-HEADER>0000930413-07-007411.hdr.sgml : 20070912
<ACCEPTANCE-DATETIME>20070912212528
ACCESSION NUMBER:		0000930413-07-007411
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070904
FILED AS OF DATE:		20070912
DATE AS OF CHANGE:		20070912

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Li Lin Ling
		CENTRAL INDEX KEY:			0001411870

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52807
		FILM NUMBER:		071114370

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		865386203897

	MAIL ADDRESS:	
		STREET 1:		14 EAST HUSHAN ROAD
		STREET 2:		TAIAN CITY
		CITY:			SHANDONG
		STATE:			F4
		ZIP:			271000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			China Biologic Products, Inc.
		CENTRAL INDEX KEY:			0001369868
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			F4
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		NO.14 EAST HUSHAN ROAD
		CITY:			TAI'AN CITY, SHANDONG
		STATE:			F4
		ZIP:			271000
		BUSINESS PHONE:		86-538-620-3897

	MAIL ADDRESS:	
		STREET 1:		NO.14 EAST HUSHAN ROAD
		CITY:			TAI'AN CITY, SHANDONG
		STATE:			F4
		ZIP:			271000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRC Holdings, Inc.
		DATE OF NAME CHANGE:	20060721
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>c50291_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2007-09-04</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001369868</issuerCik>
        <issuerName>China Biologic Products, Inc.</issuerName>
        <issuerTradingSymbol>CBPO.OB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001411870</rptOwnerCik>
            <rptOwnerName>Li Lin Ling</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>14 EAST HUSHAN ROAD</rptOwnerStreet1>
            <rptOwnerStreet2>TAIAN CITY</rptOwnerStreet2>
            <rptOwnerCity>SHANDONG</rptOwnerCity>
            <rptOwnerState>F4</rptOwnerState>
            <rptOwnerZipCode>271000</rptOwnerZipCode>
            <rptOwnerStateDescription>CHINA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>1</isOther>
            <otherText>Controlling Shareholder</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Shares</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>6862624</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <remarks>Report on a separate line for each class of securities beneficially owned directly or indirectly.</remarks>

    <ownerSignature>
        <signatureName>/s/ Lin Ling Li</signatureName>
        <signatureDate>2007-09-12</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----